Delusional Misidentification Syndromes: Drug Treatment Options

J. Arturo Silva, Gregory B. Leong, Alexander L. Miller

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


Delusional misidentification syndromes (DMSs) involve the delusional misidentification of the physical and/or psychological identity of the self or others. DMSs always exist in association with a specific mental disorder. The treatment of DMSs usually follows the treatment of the underlying mental disorder. From an aetiological standpoint, DMSs may be grouped as being associated with either a functional psychosis or a psychotic disorder secondary to a general medical condition. Additionally, associated mood psychopathology is not uncommon. The mainstay of treatment of DMSs involves antipsychotic medication, but various thymoleptics and electroconvulsive therapy (ECT) have an important role in treatment. Supportive psychological therapy can also be an important therapeutic adjunct.

Original languageEnglish (US)
Pages (from-to)89-102
Number of pages14
JournalCNS Drugs
Issue number2
StatePublished - 1996

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Pharmacology (medical)


Dive into the research topics of 'Delusional Misidentification Syndromes: Drug Treatment Options'. Together they form a unique fingerprint.

Cite this